Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey M Witkin

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Pharmacology, Biochemistry, and Behavior|February 17, 2022
The romantic age of pharmacological scienceJeffrey M Witkin
Current Protocols in Neuroscience|October 31, 2008
Animal models of obsessive-compulsive disorderJeffrey M Witkin
CNS & Neurological Disorders Drug Targets|October 18, 2011
Commentary [the mood in the field of antidepressant drug discovery]Jeffrey M Witkin
Pharmacology, Biochemistry, and Behavior|January 20, 2020
mGlu2/3 receptor antagonism: A mechanism to induce rapid antidepressant effects without ketamine-associated side-effectsJeffrey M Witkin
Advances in Pharmacology (San Diego, Calif.)|August 6, 2019
PrefaceJeffrey M Witkin
Psychopharmacology|October 10, 2002
Some contextual and historical determinants of the effects of chlordiazepoxide on punished responding of ratsJeffrey M Witkin
CNS & Neurological Disorders Drug Targets|January 31, 2015
Commentary: obstacles to the discovery of medicines for psychiatric disorders in modern timesJeffrey M Witkin
Advances in Pharmacology (San Diego, Calif.)|March 17, 2010
New approaches to the pharmacological management of major depressive disorderJeffrey M Witkin, Xia Li
CNS & Neurological Disorders Drug Targets|April 12, 2013
Curcumin, an active constiuent of the ancient medicinal herb Curcuma longa L.: some uses and the establishment and biological basis of medical efficacyJeffrey M Witkin, Xia Li
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 14, 2023
Potentiation of AMPA receptors for rapid therapeutic gain in psychiatry has reached a new level of excitementJeffrey M Witkin, Arnold Lippa
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Pharmacology, Biochemistry, and Behavior|February 17, 2022
The romantic age of pharmacological scienceJeffrey M Witkin
Current Protocols in Neuroscience|October 31, 2008
Animal models of obsessive-compulsive disorderJeffrey M Witkin
CNS & Neurological Disorders Drug Targets|October 18, 2011
Commentary [the mood in the field of antidepressant drug discovery]Jeffrey M Witkin
Pharmacology, Biochemistry, and Behavior|January 20, 2020
mGlu2/3 receptor antagonism: A mechanism to induce rapid antidepressant effects without ketamine-associated side-effectsJeffrey M Witkin
Advances in Pharmacology (San Diego, Calif.)|August 6, 2019
PrefaceJeffrey M Witkin
Psychopharmacology|October 10, 2002
Some contextual and historical determinants of the effects of chlordiazepoxide on punished responding of ratsJeffrey M Witkin
CNS & Neurological Disorders Drug Targets|January 31, 2015
Commentary: obstacles to the discovery of medicines for psychiatric disorders in modern timesJeffrey M Witkin
Advances in Pharmacology (San Diego, Calif.)|March 17, 2010
New approaches to the pharmacological management of major depressive disorderJeffrey M Witkin, Xia Li
CNS & Neurological Disorders Drug Targets|April 12, 2013
Curcumin, an active constiuent of the ancient medicinal herb Curcuma longa L.: some uses and the establishment and biological basis of medical efficacyJeffrey M Witkin, Xia Li
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 14, 2023
Potentiation of AMPA receptors for rapid therapeutic gain in psychiatry has reached a new level of excitementJeffrey M Witkin, Arnold Lippa
Pageof 13